APO Research

APO RESEARCH · REPORT

IT-enabled Healthcare

Selected research

Market Outlook & Growth Opportunities

Global IT-enabled Healthcare Market Outlook and Growth Opportunities 2026

Market perspective

The global IT-enabled Healthcare market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for IT-enabled Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for IT-enabled Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for IT-enabled Healthcare is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the IT-enabled Healthcare market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the IT-enabled Healthcare market include Aerotel Medical Systems, Allscripts, AT &T, eHealth Technologies, GE Healthcare, McKeson, Siemens, B-soft Co.,ltd and DHC Software Co.,Ltd., among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global IT-enabled Healthcare market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of IT-enabled Healthcare and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents IT-enabled Healthcare revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global IT-enabled Healthcare market.

IT-enabled Healthcare Segment by Company

Aerotel Medical Systems

Allscripts

AT &T

eHealth Technologies

GE Healthcare

McKeson

Siemens

B-soft Co.,ltd

DHC Software Co.,Ltd.

Heren Health Co.,Ltd

Sichuan Jiuyuan Yinhai Software Co.,ltd.

Johnson & Johnson

Hangzhou Century Co.,Ltd

Winning Health Technology Group Co.,Ltd.

IT-enabled Healthcare Segment by Type

Hospital Resource Planning System

Hospital Information System

Medical IoT system

Medical Artificial Intelligence system

Medical Big Data System

Electronic Medical Records

IT-enabled Healthcare Segment by Application

Clinics

Hospitals

Household

Others

IT-enabled Healthcare Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global IT-enabled Healthcare status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the IT-enabled Healthcare key companies, revenue, market share, and recent developments.

3. To split the IT-enabled Healthcare breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions IT-enabled Healthcare market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify IT-enabled Healthcare significant trends, drivers, influence factors in global and regions.

6. To analyze IT-enabled Healthcare competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global IT-enabled Healthcare market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of IT-enabled Healthcare and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of IT-enabled Healthcare.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global IT-enabled Healthcare industry.

Chapter 3: Detailed analysis of IT-enabled Healthcare company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of IT-enabled Healthcare in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of IT-enabled Healthcare in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. IT-enabled Healthcare Industry Trends Table 2. IT-enabled Healthcare Industry Drivers Table 3. IT-enabled Healthcare Industry Opportunities and Challenges Table 4. IT-enabled Healthcare Industry Restraints Table 5. Global IT-enabled Healthcare Revenue by Company (US$ Million) & (2021-2026) Table 6. Global IT-enabled Healthcare Revenue Share by Company (2021-2026) Table 7. Global IT-enabled Healthcare Company Ranking, (2024-2026) & (US$ Million) Table 8. Global IT-enabled Healthcare Key Company Manufacturing Base & Headquarters Table 9. Global IT-enabled Healthcare Company, Product Type & Application Table 10. Global IT-enabled Healthcare Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global IT-enabled Healthcare by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Hospital Resource Planning System Table 15. Significant Companies of Hospital Information System Table 16. Significant Companies of Medical IoT system Table 17. Significant Companies of Medical Artificial Intelligence system Table 18. Significant Companies of Medical Big Data System Table 19. Significant Companies of Electronic Medical Records Table 20. Global IT-enabled Healthcare Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global IT-enabled Healthcare Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global IT-enabled Healthcare Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global IT-enabled Healthcare Sales Value Share by Type (2021-2026) Table 24. Global IT-enabled Healthcare Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Clinics Table 26. Significant Companies of Hospitals Table 27. Significant Companies of Household Table 28. Significant Companies of Others Table 29. Global IT-enabled Healthcare Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global IT-enabled Healthcare Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global IT-enabled Healthcare Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global IT-enabled Healthcare Sales Value Share by Application (2021-2026) Table 33. Global IT-enabled Healthcare Sales Value Share by Application (2027-2032) Table 34. Global IT-enabled Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global IT-enabled Healthcare Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global IT-enabled Healthcare Sales Value Share by Region (2021-2026) Table 37. Global IT-enabled Healthcare Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global IT-enabled Healthcare Sales Value Share by Region (2027-2032) Table 39. Global IT-enabled Healthcare Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global IT-enabled Healthcare Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global IT-enabled Healthcare Sales Value Market Share by Country (2021-2026) Table 42. Global IT-enabled Healthcare Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global IT-enabled Healthcare Sales Value Market Share by Country (2027-2032) Table 44. Aerotel Medical Systems Company Information Table 45. Aerotel Medical Systems Business Overview Table 46. Aerotel Medical Systems IT-enabled Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Aerotel Medical Systems IT-enabled Healthcare Product Portfolio Table 48. Aerotel Medical Systems Recent Development Table 49. Allscripts Company Information Table 50. Allscripts Business Overview Table 51. Allscripts IT-enabled Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Allscripts IT-enabled Healthcare Product Portfolio Table 53. Allscripts Recent Development Table 54. AT &T Company Information Table 55. AT &T Business Overview Table 56. AT &T IT-enabled Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. AT &T IT-enabled Healthcare Product Portfolio Table 58. AT &T Recent Development Table 59. eHealth Technologies Company Information Table 60. eHealth Technologies Business Overview Table 61. eHealth Technologies IT-enabled Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. eHealth Technologies IT-enabled Healthcare Product Portfolio Table 63. eHealth Technologies Recent Development Table 64. GE Healthcare Company Information Table 65. GE Healthcare Business Overview Table 66. GE Healthcare IT-enabled Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. GE Healthcare IT-enabled Healthcare Product Portfolio Table 68. GE Healthcare Recent Development Table 69. McKeson Company Information Table 70. McKeson Business Overview Table 71. McKeson IT-enabled Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. McKeson IT-enabled Healthcare Product Portfolio Table 73. McKeson Recent Development Table 74. Siemens Company Information Table 75. Siemens Business Overview Table 76. Siemens IT-enabled Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Siemens IT-enabled Healthcare Product Portfolio Table 78. Siemens Recent Development Table 79. B-soft Co.,ltd Company Information Table 80. B-soft Co.,ltd Business Overview Table 81. B-soft Co.,ltd IT-enabled Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. B-soft Co.,ltd IT-enabled Healthcare Product Portfolio Table 83. B-soft Co.,ltd Recent Development Table 84. DHC Software Co.,Ltd. Company Information Table 85. DHC Software Co.,Ltd. Business Overview Table 86. DHC Software Co.,Ltd. IT-enabled Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. DHC Software Co.,Ltd. IT-enabled Healthcare Product Portfolio Table 88. DHC Software Co.,Ltd. Recent Development Table 89. Heren Health Co.,Ltd Company Information Table 90. Heren Health Co.,Ltd Business Overview Table 91. Heren Health Co.,Ltd IT-enabled Healthcare Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Heren Health Co.,Ltd IT-enabled Healthcare Product Portfolio Table 93. Heren Health Co.,Ltd Recent Development Table 94. Sichuan Jiuyuan Yinhai Software Co.,ltd. Company Information Table 95. Sichuan Jiuyuan Yinhai Software Co.,ltd. Business Overview Table 96. Sichuan Jiuyuan Yinhai Software Co.,ltd. IT-enabled Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Sichuan Jiuyuan Yinhai Software Co.,ltd. IT-enabled Healthcare Product Portfolio Table 98. Sichuan Jiuyuan Yinhai Software Co.,ltd. Recent Development Table 99. Johnson & Johnson Company Information Table 100. Johnson & Johnson Business Overview Table 101. Johnson & Johnson IT-enabled Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Johnson & Johnson IT-enabled Healthcare Product Portfolio Table 103. Johnson & Johnson Recent Development Table 104. Hangzhou Century Co.,Ltd Company Information Table 105. Hangzhou Century Co.,Ltd Business Overview Table 106. Hangzhou Century Co.,Ltd IT-enabled Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Hangzhou Century Co.,Ltd IT-enabled Healthcare Product Portfolio Table 108. Hangzhou Century Co.,Ltd Recent Development Table 109. Winning Health Technology Group Co.,Ltd. Company Information Table 110. Winning Health Technology Group Co.,Ltd. Business Overview Table 111. Winning Health Technology Group Co.,Ltd. IT-enabled Healthcare Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. Winning Health Technology Group Co.,Ltd. IT-enabled Healthcare Product Portfolio Table 113. Winning Health Technology Group Co.,Ltd. Recent Development Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. IT-enabled Healthcare Product Image Figure 2. Global IT-enabled Healthcare Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global IT-enabled Healthcare Market Size (2021-2032) & (US$ Million) Figure 4. Global IT-enabled Healthcare Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Hospital Resource Planning System Image Figure 8. Hospital Information System Image Figure 9. Medical IoT system Image Figure 10. Medical Artificial Intelligence system Image Figure 11. Medical Big Data System Image Figure 12. Electronic Medical Records Image Figure 13. Global IT-enabled Healthcare Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global IT-enabled Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global IT-enabled Healthcare Sales Value Share by Type (2021-2032) Figure 16. Clinics Image Figure 17. Hospitals Image Figure 18. Household Image Figure 19. Others Image Figure 20. Global IT-enabled Healthcare Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global IT-enabled Healthcare Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global IT-enabled Healthcare Sales Value Share by Application (2021-2032) Figure 23. Global IT-enabled Healthcare Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global IT-enabled Healthcare Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America IT-enabled Healthcare Sales Value (2021-2032) & (US$ Million) Figure 26. North America IT-enabled Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe IT-enabled Healthcare Sales Value (2021-2032) & (US$ Million) Figure 28. Europe IT-enabled Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific IT-enabled Healthcare Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific IT-enabled Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America IT-enabled Healthcare Sales Value (2021-2032) & (US$ Million) Figure 32. South America IT-enabled Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa IT-enabled Healthcare Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa IT-enabled Healthcare Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt IT-enabled Healthcare Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Hospital Resource Planning System
  • Hospital Information System
  • Medical IoT system
  • Medical Artificial Intelligence system
  • Medical Big Data System
  • Electronic Medical Records
Applications
  • Clinics
  • Hospitals
  • Household
  • Others
Companies covered
  • Aerotel Medical Systems
  • Allscripts
  • AT &T
  • eHealth Technologies
  • GE Healthcare
  • McKeson
  • Siemens
  • B-soft Co.,ltd
  • DHC Software Co.,Ltd.
  • Heren Health Co.,Ltd
  • Sichuan Jiuyuan Yinhai Software Co.,ltd.
  • Johnson & Johnson
  • Hangzhou Century Co.,Ltd
  • Winning Health Technology Group Co.,Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global IT-enabled Healthcare Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global IT-enabled Healthcare Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 IT-enabled Healthcare Market Dynamics
  1. 2.1 IT-enabled Healthcare Industry Trends
  2. 2.2 IT-enabled Healthcare Industry Drivers
  3. 2.3 IT-enabled Healthcare Industry Opportunities and Challenges
  4. 2.4 IT-enabled Healthcare Industry Restraints
3 IT-enabled Healthcare Market by Company
  1. 3.1 Global IT-enabled Healthcare Company Revenue Ranking in 2025
  2. 3.2 Global IT-enabled Healthcare Revenue by Company (2021-2026)
  3. 3.3 Global IT-enabled Healthcare Company Ranking (2024-2026)
  4. 3.4 Global IT-enabled Healthcare Company Manufacturing Base and Headquarters
  5. 3.5 Global IT-enabled Healthcare Company Product Type and Application
  6. 3.6 Global IT-enabled Healthcare Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global IT-enabled Healthcare Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 IT-enabled Healthcare Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 IT-enabled Healthcare Market by Type
  1. 4.1 IT-enabled Healthcare Type Introduction
  2. 4.1.1 Hospital Resource Planning System
  3. 4.1.2 Hospital Information System
  4. 4.1.3 Medical IoT system
  5. 4.1.4 Medical Artificial Intelligence system
  6. 4.1.5 Medical Big Data System
  7. 4.1.6 Electronic Medical Records
  8. 4.2 Global IT-enabled Healthcare Sales Value by Type
  9. 4.2.1 Global IT-enabled Healthcare Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global IT-enabled Healthcare Sales Value by Type (2021-2032)
  11. 4.2.3 Global IT-enabled Healthcare Sales Value Share by Type (2021-2032)
5 IT-enabled Healthcare Market by Application
  1. 5.1 IT-enabled Healthcare Application Introduction
  2. 5.1.1 Clinics
  3. 5.1.2 Hospitals
  4. 5.1.3 Household
  5. 5.1.4 Others
  6. 5.2 Global IT-enabled Healthcare Sales Value by Application
  7. 5.2.1 Global IT-enabled Healthcare Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global IT-enabled Healthcare Sales Value by Application (2021-2032)
  9. 5.2.3 Global IT-enabled Healthcare Sales Value Share by Application (2021-2032)
6 IT-enabled Healthcare Regional Value Analysis
  1. 6.1 Global IT-enabled Healthcare Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global IT-enabled Healthcare Sales Value by Region (2021-2032)
  3. 6.2.1 Global IT-enabled Healthcare Sales Value by Region: 2021-2026
  4. 6.2.2 Global IT-enabled Healthcare Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America IT-enabled Healthcare Sales Value (2021-2032)
  7. 6.3.2 North America IT-enabled Healthcare Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe IT-enabled Healthcare Sales Value (2021-2032)
  10. 6.4.2 Europe IT-enabled Healthcare Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific IT-enabled Healthcare Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific IT-enabled Healthcare Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America IT-enabled Healthcare Sales Value (2021-2032)
  16. 6.6.2 South America IT-enabled Healthcare Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa IT-enabled Healthcare Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa IT-enabled Healthcare Sales Value Share by Country, 2025 VS 2032
7 IT-enabled Healthcare Country-level Value Analysis
  1. 7.1 Global IT-enabled Healthcare Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global IT-enabled Healthcare Sales Value by Country (2021-2032)
  3. 7.2.1 Global IT-enabled Healthcare Sales Value by Country (2021-2026)
  4. 7.2.2 Global IT-enabled Healthcare Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt IT-enabled Healthcare Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt IT-enabled Healthcare Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt IT-enabled Healthcare Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Aerotel Medical Systems
  2. 8.1.1 Aerotel Medical Systems Company Information
  3. 8.1.2 Aerotel Medical Systems Business Overview
  4. 8.1.3 Aerotel Medical Systems IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Aerotel Medical Systems IT-enabled Healthcare Product Portfolio
  6. 8.1.5 Aerotel Medical Systems Recent Developments
  7. 8.2 Allscripts
  8. 8.2.1 Allscripts Company Information
  9. 8.2.2 Allscripts Business Overview
  10. 8.2.3 Allscripts IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Allscripts IT-enabled Healthcare Product Portfolio
  12. 8.2.5 Allscripts Recent Developments
  13. 8.3 AT &T
  14. 8.3.1 AT &T Company Information
  15. 8.3.2 AT &T Business Overview
  16. 8.3.3 AT &T IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  17. 8.3.4 AT &T IT-enabled Healthcare Product Portfolio
  18. 8.3.5 AT &T Recent Developments
  19. 8.4 eHealth Technologies
  20. 8.4.1 eHealth Technologies Company Information
  21. 8.4.2 eHealth Technologies Business Overview
  22. 8.4.3 eHealth Technologies IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  23. 8.4.4 eHealth Technologies IT-enabled Healthcare Product Portfolio
  24. 8.4.5 eHealth Technologies Recent Developments
  25. 8.5 GE Healthcare
  26. 8.5.1 GE Healthcare Company Information
  27. 8.5.2 GE Healthcare Business Overview
  28. 8.5.3 GE Healthcare IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  29. 8.5.4 GE Healthcare IT-enabled Healthcare Product Portfolio
  30. 8.5.5 GE Healthcare Recent Developments
  31. 8.6 McKeson
  32. 8.6.1 McKeson Company Information
  33. 8.6.2 McKeson Business Overview
  34. 8.6.3 McKeson IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  35. 8.6.4 McKeson IT-enabled Healthcare Product Portfolio
  36. 8.6.5 McKeson Recent Developments
  37. 8.7 Siemens
  38. 8.7.1 Siemens Company Information
  39. 8.7.2 Siemens Business Overview
  40. 8.7.3 Siemens IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Siemens IT-enabled Healthcare Product Portfolio
  42. 8.7.5 Siemens Recent Developments
  43. 8.8 B-soft Co.,ltd
  44. 8.8.1 B-soft Co.,ltd Company Information
  45. 8.8.2 B-soft Co.,ltd Business Overview
  46. 8.8.3 B-soft Co.,ltd IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  47. 8.8.4 B-soft Co.,ltd IT-enabled Healthcare Product Portfolio
  48. 8.8.5 B-soft Co.,ltd Recent Developments
  49. 8.9 DHC Software Co.,Ltd.
  50. 8.9.1 DHC Software Co.,Ltd. Company Information
  51. 8.9.2 DHC Software Co.,Ltd. Business Overview
  52. 8.9.3 DHC Software Co.,Ltd. IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  53. 8.9.4 DHC Software Co.,Ltd. IT-enabled Healthcare Product Portfolio
  54. 8.9.5 DHC Software Co.,Ltd. Recent Developments
  55. 8.10 Heren Health Co.,Ltd
  56. 8.10.1 Heren Health Co.,Ltd Company Information
  57. 8.10.2 Heren Health Co.,Ltd Business Overview
  58. 8.10.3 Heren Health Co.,Ltd IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Heren Health Co.,Ltd IT-enabled Healthcare Product Portfolio
  60. 8.10.5 Heren Health Co.,Ltd Recent Developments
  61. 8.11 Sichuan Jiuyuan Yinhai Software Co.,ltd.
  62. 8.11.1 Sichuan Jiuyuan Yinhai Software Co.,ltd. Company Information
  63. 8.11.2 Sichuan Jiuyuan Yinhai Software Co.,ltd. Business Overview
  64. 8.11.3 Sichuan Jiuyuan Yinhai Software Co.,ltd. IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sichuan Jiuyuan Yinhai Software Co.,ltd. IT-enabled Healthcare Product Portfolio
  66. 8.11.5 Sichuan Jiuyuan Yinhai Software Co.,ltd. Recent Developments
  67. 8.12 Johnson & Johnson
  68. 8.12.1 Johnson & Johnson Company Information
  69. 8.12.2 Johnson & Johnson Business Overview
  70. 8.12.3 Johnson & Johnson IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Johnson & Johnson IT-enabled Healthcare Product Portfolio
  72. 8.12.5 Johnson & Johnson Recent Developments
  73. 8.13 Hangzhou Century Co.,Ltd
  74. 8.13.1 Hangzhou Century Co.,Ltd Company Information
  75. 8.13.2 Hangzhou Century Co.,Ltd Business Overview
  76. 8.13.3 Hangzhou Century Co.,Ltd IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hangzhou Century Co.,Ltd IT-enabled Healthcare Product Portfolio
  78. 8.13.5 Hangzhou Century Co.,Ltd Recent Developments
  79. 8.14 Winning Health Technology Group Co.,Ltd.
  80. 8.14.1 Winning Health Technology Group Co.,Ltd. Company Information
  81. 8.14.2 Winning Health Technology Group Co.,Ltd. Business Overview
  82. 8.14.3 Winning Health Technology Group Co.,Ltd. IT-enabled Healthcare Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Winning Health Technology Group Co.,Ltd. IT-enabled Healthcare Product Portfolio
  84. 8.14.5 Winning Health Technology Group Co.,Ltd. Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research